Vol. 8 (01) pp. 960-962 DOI: 10.21474/IJAR01/10387

CARBAMAZEPINE INDUCED DRESS SYNDROME : A CASE REPORT

  • Department of Pharmacy Practice, GIET School of Pharmacy, Rajahmundry, Andhra Pradesh, India.
  • Department of Dermatology, GSL General Hospital, Rajahmundry, Andhra Pradesh, India.
31 Downloads 147 Views
Crossref

Abstract

The Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) presents clinically as an extensive mucocutaneous rash, accompanied by fever, lymphadenopathy, hepatitis and hematological abnormalities with eosinophilia & atypical lymphocytes. It may cause damage to several organs, especially to the kidneys, heart, lungs and pancreas. The mortality rate is approximately 10% and the rate of incidence of dress syndrome ranges from 1 in 1,000 to 1 in 10,000 drug exposures. There are around 50 culprit drugs which can induce dress syndrome. Among these, Carbamazepine and Allopurinol are the most commonly observed drugs that induce this syndrome. In this case report, we discussed regarding a 56 years old female patient who was diagnosed with Carbamazepine induced Dress Syndrome. The clinical manifestations of this disease are quite similar to many disease conditions which might lead to misconception. Along with the prevailing manifestations, it is essential to correlate the past medical & medication history and laboratory findings to make an accurate diagnosis. A multidisciplinary approach must be required for early cessation of the suspected drug and initiation of the symptomatic therapy in order to provide a better supportive care to the patient in the clinical scenario. This prevents the further complications thus paving a way for the improvement of the quality of life in the patients.

Keywords

Article Analytics

References

  1. Abhishek De, MurlidharRajagopalan, Projna Biswas. Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature. Indian journal of dermatology 2018;63(1):30-40.
  2. EfnanCahk, BetulCavusogluTurker, Suleymanahbad, hayriyeEsraAtaoglu. Carbamazepine induced DRESS syndrome. International journal of contemporary medical research 2017;4(12):2393-2915.
  3. Damor, Rahul R, kubavat, Amita R, Piparav, KiranG. Drug reaction with eosinophilia and systemic symptom induced by carbamazepine: a case report. International Journal of Basic & Clinical Pharmacology 2019;8(5):1115-1118.
  4. Gancheva T, Gancheva D, Troeva Z, Velev V, Hristakieva E, Tsokeva Z. Carbamazepine-induced DRESS syndrome: a case report. J Pharmacol 2017;5(1):1063.
  5. Dursun A, KacarBayram A, UlgenTekerek N, Akyıldız BN, Per H. A case of DRESS syndrome associated with carbamazepine treatment. Turk PediatriArs 2018;53:48-50.
  6. Lal J, Sharma A, Jaiswal S. Carbamazepine pharmacokinetic and drug interactions in poly-treated patients. In: Gallelli L, editor.Carbamazepine: Medical Uses, Pharmacokinetics and Adverse Effects. NOVA Science Publishers Inc 2013;1-32.
  7. S. Food and Drug Administration. Tegretol. Prescribing information.
  8. E L omairi N, Abourazzak S, Chaouki S, Atmani S, Hida M. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review. Pan AfrMed J 2014;18:9.
  9. Waseem D, Latief M, Sofi N, Dar I, Khan Q. DRESS syndrome: a review and update. Skin Dis Skin Care 2016;1:1.
  10. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Seminars Cutaneous Med Surg 1996;15(4):250-257.
  11. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk. J Clin Investigation 1988;82(6):1826-1832.
  12. Mockenhaupt M. Epidemiology of cutaneous adversedrug reactions. ChemImmunol Allergy 2012;97:1-17.
  13. Knowles SR, Dewhurst N, Shear NH. Anticonvulsant hypersensitivity syndrome: an update. Expert Opin Drug Saf 2012;11:767-778.
  14. Kardaun SH, Sekula P, Valeyrie-Allanore L. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multy system adverse drug reaction.Br J Dermatol 2013;169:1071-1080.
  15. Bayram AK, Canpolat M, Cinar SL. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient. J Emerg Med 2016;50:61-66.
  16. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist. Br J Dermatol 2007;156:609-611.

How to Cite This Article

Sireesha Maram, Ramam Sripada, Himabindu Mylapalli, Sudeepthi Padala, Subhashini Konala, Satya Saka, Vamsi Bhukya and Dasaratha Dhanaraju Magharla (2020); CARBAMAZEPINE INDUCED DRESS SYNDROME : A CASE REPORT, Int. J. of Adv. Res., 8 (01), 960-962, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/10387

Corresponding Author

RAMAM SRIPADA
GIET SCHOOL OF PHARMACY